Atrial myocardium is the predominant inotropic target of adrenomedullin in the human heart.
Adrenomedullin (ADM) is an endogenous peptide with favorable hemodynamic effects in vivo. In this study, we characterized the direct functional effects of ADM in isolated preparations from human atria and ventricles. In electrically stimulated human nonfailing right atrial trabeculae, ADM (0.0001-1 micromol/l) increased force of contraction in a concentration-dependent manner, with a maximal increase by 35 +/- 8% (at 1 micromol/l; P < 0.05). The positive inotropic effect was accompanied by a disproportionate increase in calcium transients assessed by aequorin light emission [by 76 +/- 20%; force/light ratio (DeltaF/DeltaL) 0.58 +/- 0.15]. In contrast, elevation of extracellular calcium (from 2.5 to 3.2 mmol/l) proportionally increased force and aequorin light emission (DeltaF/DeltaL 1.0 +/- 0.1; P < 0.05 vs. ADM). Consistent with a cAMP-dependent mechanism, ADM (1 micromol/l) increased atrial cAMP levels by 90 +/- 12%, and its inotropic effects could be blocked by the protein kinase A (PKA) inhibitor H-89. ADM also exerted positive inotropic effects in failing atrial myocardium and in nonfailing and failing ventricular myocardium. The inotropic response was significantly weaker in ventricular vs. atrial myocardium and in failing vs. nonfailing myocardium. In conclusion, ADM exerts Ca(2+)-dependent positive inotropic effects in human atrial and less-pronounced effects in ventricular myocardium. The inotropic effects are related to increased cAMP levels and stimulation of PKA. In heart failure, the responsiveness to ADM is reduced in atria and ventricles.
Bisping
Egbert
E
Department of Cardiology, University of Göttingen, Göttingen, Germany.
Tenderich
Gero
G
Barckhausen
Paul
P
Stumme
Burkhard
B
Bruns
Sebastian
S
von Lewinski
Dirk
D
Pieske
Burkert
B
D053607:Adrenomedullin / Q000008:administration & dosage*; D002316:Cardiotonic Agents; D004305:Dose-Response Relationship, Drug; D006325:Heart Atria; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects*; D018487:Ventricular Dysfunction, Left / Q000503:physiopathology*
D002316:Cardiotonic Agents; D053607:Adrenomedullin